MAP2K7 and lung carcinoma: Yoon et al. shows that combined STAT3 inhibition with MEK inhibition restrains STAT3 activation, resulting in synergistical suppression of cell growth and stimulation of apoptosis in KRAS mutant lung cancer cells [3].